Physician profile
Seema C Modi
NPI 1043204423
$937.21
in general payments reported to CMS, 2019-2025
18 companies · $798 in 2025
The $798 reported for 2025 was more than what 88% of Geriatric Medicine (Family Medicine) providers received nationally (typical 2025 total: $119).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $13.20 · 2024: $126 · 2025: $798.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $937.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $937.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $152.30 | 2024-2025 | Dexcom G6 Transmitter |
| Abbvie INC. | $140.45 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $135.40 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $91.07 | 2025 | Jardiance, Jascayd |
| Novo Nordisk INC | $75.07 | 2025 | Wegovy, Rybelsus, Ozempic |
| Glaxosmithkline, LLC. | $60.09 | 2025 | Arexvy, Shingrix |
| Pfizer INC. | $43.93 | 2025 | |
| Astellas Pharma US INC | $33.81 | 2025 | Veozah |
| Renalytix Ai, INC. | $30.95 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Lilly USA, LLC | $27.69 | 2025 | Mounjaro, Zepbound |
| Corcept Therapeutics | $25.17 | 2025 | Korlym |
| Janssen Pharmaceuticals, INC | $20.41 | 2025 | Spravato |
| Abbott Laboratories | $19.36 | 2025 | Freestyle Libre 3 |
| Azurity Pharmaceuticals, INC. | $19.25 | 2025 | Azmiro |
| Exact Sciences Corporation | $18.34 | 2025 | Cologuard Collection Kit |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $16.40 | 2025 | Repatha |
| Biotronik Nro, INC. | $14.32 | 2024 | Prospera |
| Boston Scientific Corporation | $13.20 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seema Modi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.